mProX™ Human MET Stable Cell Line

Biosafety Level

Level 1

Activity

Yes

Quantity

10⁶ cells per vial

Applications

MET (Motivational Enhancement Therapy) appears to be used in a variety of contexts. One study focused on the use of behavioural economic interventions to reduce non-attendance for healthcare appointments. These interventions aimed to persuade, nudge, and incentivize patients to attend their scheduled appointments. The most common intervention assessed in this study was the use of reminders, such as SMS, telephone, or mail reminders. Another study explored the use of protein supplementation and exercise in older adults with sarcopenic obesity. The study found that whey protein supplementation, combined with exercise training, was effective in improving sarcopenic conditions and weight status. Additionally, MET was used to assess the impact of body mass index (BMI) on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors. The study found that overweight and obese patients tended to achieve prolonged survival time with these treatments. Finally, MET was used to develop a prehospital instrument, called the Pelvic Vascular Injury Score (P-VIS), for detecting significant vascular injury in patients with pelvic fractures. The P-VIS incorporated predictive factors to assess the probability of vascular injury and guide prehospital trauma management. Overall, MET is used in a range of applications, including healthcare appointment attendance, sarcopenic obesity, cancer treatment, and trauma management.